Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Gout Drug Recalled
05/28/2020
The FDA is recalling a prescription medication that reduces uric acid, and also treats gout and kidney stones.
The FDA is recalling a prescription medication that reduces uric acid, and also treats gout and kidney stones.
The FDA is recalling a...
05/28/2020
Pharmacy Learning Network
News
Particulate Matter in Injection Prompts Class I Recall
05/28/2020
An injection used for parenteral replacement of extracellular losses of fluid and electrolytes is being recalled.
An injection used for parenteral replacement of extracellular losses of fluid and electrolytes is being recalled.
An injection used for parenteral...
05/28/2020
Pharmacy Learning Network

Advertisement

News
Slight Bump in Flu Vaccination Rates With Patient Portal Reminders
05/21/2020
“Generic patient portal reminders were effective in minimally increasing influenza vaccination rates, but more intensive or more targeted patient motivational strategies appear to be needed,” researchers wrote. 
“Generic patient portal reminders were effective in minimally increasing influenza vaccination rates, but more intensive or more targeted patient motivational strategies appear to be needed,” researchers wrote. 
“Generic patient portal...
05/21/2020
Pharmacy Learning Network
News
Alzheimer Med Recalled
05/21/2020
The recall of a prescription medication used to treat moderate to severe dementia associated with Alzheimer disease is active in six states.
The recall of a prescription medication used to treat moderate to severe dementia associated with Alzheimer disease is active in six states.
The recall of a prescription...
05/21/2020
Pharmacy Learning Network
News
Class I Recall for Hair Loss Drug
05/21/2020
The FDA has issued a Class I recall for a compounded prescription medication used to treat hair loss.
The FDA has issued a Class I recall for a compounded prescription medication used to treat hair loss.
The FDA has issued a Class I...
05/21/2020
Pharmacy Learning Network

Advertisement

News
Immune System Alterations Occur Early on in the Development of Multiple Myeloma
05/19/2020
This study represents the first time that single-cell RNA sequencing has been employed to detect features of the immune microenvironment in myeloma precursor conditions.
This study represents the first time that single-cell RNA sequencing has been employed to detect features of the immune microenvironment in myeloma precursor conditions.
This study represents the first...
05/19/2020
Pharmacy Learning Network
News
Clinical Decision Support Tool for Back Pain Earns High Marks From Pharmacists
05/15/2020
Researchers found that an electronic clinical decision support system designed to guide pharmacists’ recommendations for patients with low back pain earned high ratings for usability and acceptance among pharmacists.
Researchers found that an electronic clinical decision support system designed to guide pharmacists’ recommendations for patients with low back pain earned high ratings for usability and acceptance among pharmacists.
Researchers found that an...
05/15/2020
Pharmacy Learning Network
News
Opioid Prescribing Often Fails to Align with Guidelines, Study Finds
05/15/2020
“These results may reflect low clinician awareness of applicable guidelines or reluctance to adhere to guidance,” researchers wrote.
“These results may reflect low clinician awareness of applicable guidelines or reluctance to adhere to guidance,” researchers wrote.
“These results may reflect low...
05/15/2020
Pharmacy Learning Network

Advertisement

News
Emergency Allergy Auto-Injectors Recalled
05/15/2020
A Class II recall is active for a prescription treatment used in emergencies to treat serious allergic reactions.
A Class II recall is active for a prescription treatment used in emergencies to treat serious allergic reactions.
A Class II recall is active for...
05/15/2020
Pharmacy Learning Network
News
Proton-Pump Inhibitor Recalled
05/08/2020
The FDA is recalling a prescription proton-pump inhibitor used to treat conditions involving excess stomach acid, such as gastroesophageal reflux disease, or GERD.
The FDA is recalling a prescription proton-pump inhibitor used to treat conditions involving excess stomach acid, such as gastroesophageal reflux disease, or GERD.
The FDA is recalling a...
05/08/2020
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use